The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
about
Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's diseaseMelatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.Multicomponent, fragment-based synthesis of polyphenol-containing peptidomimetics and their inhibiting activity on beta-amyloid oligomerization.
P2860
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The Antioxidant Additive Appro ...... -Derived 2)-Like 2 Activators.
@en
The Antioxidant Additive Appro ...... -Derived 2)-Like 2 Activators.
@nl
type
label
The Antioxidant Additive Appro ...... -Derived 2)-Like 2 Activators.
@en
The Antioxidant Additive Appro ...... -Derived 2)-Like 2 Activators.
@nl
prefLabel
The Antioxidant Additive Appro ...... -Derived 2)-Like 2 Activators.
@en
The Antioxidant Additive Appro ...... -Derived 2)-Like 2 Activators.
@nl
P2093
P50
P1476
The Antioxidant Additive Appro ...... -Derived 2)-Like 2 Activators.
@en
P2093
Bernard Refouvelet
José Marco-Contelles
Lhassane Ismaili
Ondrej Soukup
P304
P356
10.1021/ACS.JMEDCHEM.6B01178
P407
P50
P577
2016-10-13T00:00:00Z